logo
Sign in

Twist Bioscience

SAN FRANCISCO, CA · Founded 2013 · Biotech · Private

Silicon-based DNA synthesis platform and synthetic DNA tools including gene synthesis, oligo pools, and NGS reagents

Claim this profile

Follows are private to you and power your alerts

Updated · twistbioscience.com

Sector
Biotech
Headquarters
SAN FRANCISCO, CA
Founded
2013
Latest Form D
$50M, Apr 2018
Total capital
$226M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$214M
7 Form D · last Apr 2018
103 months since last filing
Federal contracts
$12M
38 awards · Defense, Health and Human S, Veterans Affairs
Rank in Biotech#57 of 4373
Granted patents
22
18 pending · first 2025
Rank in peer group#3 of 342

Capital timeline

2013201520172019202120232025FEDERAL ↑EQUITY ↓Cumulative $226M$4.5M$264K$540K$5M$157K7th Form D$50M
2013201720212025FEDERAL ↑EQUITY ↓Cumulative $226M$4.5M$540K$5M7th Form D$50M

Latest events

  • Federal contractHealth and Human S · The Purpose Of This Purchase Order Is To Provide The National Institute Of Environmental Health Sciences / Division Of Translational Toxicology (dtt) / Mechanistic Toxicology Branch / Mitochondrial Toxicology And Biology Group With Twist Biosciences$27K
  • Federal contractVeterans Affairs · Methylome Sample Processing Services For The Va Long Beach Research Service.$47K
  • Federal contractJustice · Twist Bioscience Equipment$97K
  • Federal contractAgriculture · Twist 96-PLEX Library Prep Kit 10X96 Samples$61K
  • Federal contractHealth and Human S · Biological And Reagent Materials$12K
  • Federal contractVeterans Affairs · Shahrara Humanized Monoclonal Antibody For Syndecan Twist Bioscience$105K
  • Federal contractHealth and Human S · Lap Supplies$157K
  • Private capital raisedForm D · SEC · 7th filing$50M
  • Private capital raisedForm D · SEC · 6th filing$32.2M
  • Private capital raisedForm D · SEC · 5th filing$2.6M
  • Private capital raisedForm D · SEC · 4th filing$61M
  • Private capital raisedForm D · SEC · 3rd filing$37M
  • Private capital raisedForm D · SEC · 2nd filing$26M
  • Private capital raisedForm D · SEC · 1st filing$4.7M
Show 30 earlier federal awards
  • Federal contractHealth and Human S · Generation Of A Saturation Mutagenesis Cdna Library Of PINK1 Cdna$23K
  • Federal contractHealth and Human S · Oligos Pools Are Needed For A Gene Expression/ Mpra Project$22K
  • Federal contractHealth and Human S · Dr. Laura Elnitski Lab Need The Twist Custom Capture Panel For A New Blood Based Cancer Diagnostic To Detect HHV8 In Plasma Of Hiv PATIENTS.[24-004752]$14K
  • Federal contractHealth and Human S · Niddk / Twist Library Preparation Kit 1,$15K
  • Federal contractHealth and Human S · Dna Synthesis Services For Gene Cloning$22K
  • Federal contractVeterans Affairs · Ffpe Sampling$64K
  • Federal contractHealth and Human S · Custom Single Site Variant Library$24K
  • Federal contractVeterans Affairs · Methylome Sequencing$48K
  • Federal contractHealth and Human S · Twist Rna For FLUSC2 Multiple$51K
  • Federal contractHealth and Human S · Clonal Genes$14K
  • Federal contractHealth and Human S · Custom Cloned Pooled Oligo Library$78K
  • Federal contractDefense · Twist Research Panels$18K
  • Federal contractHealth and Human S · Twist Custom Panel Hybrid Probes$15K
  • Federal contractHealth and Human S · Oligo Pools$60K
  • Federal contractHealth and Human S · Cloned Oligo Pool Libraries$26K
  • Federal contractHealth and Human S · Oligo$14K
  • Federal contractHealth and Human S · Custom Oligo Library$12K
  • Federal contractHealth and Human S · Radx Tech Project 6818 Portable, Rapid, Disposable Test With Synthetic Antibodies For Testing Anywhere$5M
  • Federal contractHealth and Human S · SC2 Positive Control Synthetic Rna Control Material$540K
  • Federal contractHealth and Human S · SC2 Positive Control Synthetic Rna Control$264K
  • Federal contractHealth and Human S · Custom Oligo Library$21K
  • Federal contractHealth and Human S · Sars COV2 Rna Control$126K
  • Federal contractHealth and Human S · Sars Cov 2 Rna Controls$220K
  • Federal contractHealth and Human S · Twist Bioscience CORPORATION:1278803 [20-006609]$24K
  • Federal contractHealth and Human S · Covid Dna Contructs$98K
  • Federal contractHealth and Human S · Sars CO-V-2 Rna Controls$82K
  • Federal contractHealth and Human S · COVID-19 Dna Constructs$30K
  • Federal contractHealth and Human S · Twist Bioscience CORPORATION:1278803 [18-022534]$4K
  • Federal contractHealth and Human S · Twist Bioscience CORPORATION:1278803 [17-061421]$5K
  • Federal contractDefense · Living Foundries: 1000 Molecules TA1. Darpa's Living Foundries: 1000 Molecules Program Seeks To Build A Scalable, Integrated, Rapid Design And Prototyping Infrastructure For The Facile Engineering Of Biology. This Effort Is An Advanced Study. The Twist Effort Proposes To Develop A Large Scale, High-throughput Platform For Constructing Low-cost Genetic Designs.$4.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 342 peers

Line = median

Biotech · Platform

  • Granted patents#3 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Bill James PeckExecutive Officer, PromoterNamed in SEC Form D filings
  • Bob Marine RagusaDirectorNamed in SEC Form D filings
  • Emily Marine LeproustExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • Fred Marine CravesDirectorNamed in SEC Form D filings
  • Keith Marine CrandellDirectorNamed in SEC Form D filings
  • Minqi Marine LiDirectorNamed in SEC Form D filings
Show all 11 people
  • Nick James NaclerioDirectorNamed in SEC Form D filings
  • Paul James ConleyDirectorNamed in SEC Form D filings
  • Rob Marine ChessDirectorNamed in SEC Form D filings
  • Solange James GlaizeExecutive OfficerNamed in SEC Form D filings
  • William Charles BanyaiExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 22 granted of 40
Show all 40 patent records

Related companies, and why

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .